NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
14/01/2026
Voltar para busca
Dado oficial do USPTO
RIGEL ONE CARE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
RIGEL ONE CARE
ST13
US500000087817100Classe
35, 36, 44
Pedido
87817100
Registro
6102551
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
15/01/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36, 44
Data de depósito
01/03/2018
Data de registro
14/07/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/01/2026
Última transação
15/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2018-06-00
Primeiro uso no comércio
2018-06-00
Código do desenho
4
Tipo de titular
03
Localização do titular
South San Francisco, CA, US
Examinador
CAHILL, CLARE GALLAGHER
Localização atual
Historical data usage
Titulares e representantes
Titulares
Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc.
Representantes
Jamed J. Saul FAEGRE DRINKER BIDDLE & REATH LLP
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Providing a database for collecting and reporting information pertaining to medical treatmentinsuranceprescription drug dispensing and management for business purposes; Business administration of a patient support programwhich helps patientsin coordination with their healthcare provideraccessstartcomply with therapy as prescribedprovides co-pay assistanceassistance with insurance and healthcare providerscoverage and reimbursement informationgeneral education and supportinformation about productshealth topicsrelated resources; Providing business information and billing services in the field of healthcareproviding reimbursement informationdrug pricingpayment trackingco-payment data and other market intelligence to health care providersinsurers and consumers; Providing consumer product information relating to prescription drugs to distributorspharmacies and consumers; Distribution of product advertising materials for sales representatives of prescription drugs; Assisting patients in enrolling in pharmaceutical reimbursement programs of others; Providing a website featuring information for medical professionalspharmaciesinsurance companies and drug distributors regarding retail pharmacy business information about the administration and dosing of pharmaceuticals; Medical billing support servicesproviding an internet website portal featuring billing information to healthcare professionalspatients and patient caregivers relating to reimbursement for pharmaceutical preparationshealth care and prescription drugs
Classe 36
Advisory services and consultancy regarding healthcare benefits and pharmacy benefits; providing information and guidance in connection with healthmedicalpharmacy insurance benefit plans; insurance consultation servicesassisting physician offices and patients to identify the scope of coverage offered by patient medical and pharmaceutical insurance; insurance consultation servicesassisting physician offices and patients to obtain prior authorization for medical and pharmaceutical insurance claims and the preparation and submission of related paperwork and assisting physician offices and patients to appeal denial of medical and pharmaceutical insurance claims and the preparation and submission of related paperwork; Financial informationproviding reimbursement informationdrug pricingpayment trackingco-payment information to health care providersinsurers and consumers; Financial administration of health reimbursement arrangementsproviding an internet website portal featuring financial information to healthcare professionalspatients and patient caregivers relating to reimbursement for pharmaceutical preparationshealth care and prescription drugs
Classe 44
Medical information services; Medical informational servicesproviding information regarding prescription drugs for drug distributorsinsurance companiespharmacies and medical professionals; Providing a website featuring information for medical professionalspharmaciesinsurance companies and drug distributors regarding therapeutic properties of pharmaceuticalsthe treatment of diseases and medical conditionsmedical information about the administration and dosing of pharmaceuticals; Patient support services relating to treatment of medical disordersproviding information relating to therapeutic properties of pharmaceuticalsthe treatment of diseases and medical conditionsmedical information about the administration and dosing of pharmaceuticals; Providing a website featuring healthcare informationproviding resources in the field of pharmaceuticals for treatment of diseases and links to such resources; Medical information servicesproviding a website in the medicalpharmaceutical and health fields featuring information related to healthwellnesshealthcarepatient support servicespharmaceuticalspharmaceutical accessdrug safety and/or drug compatibility in relation to therapy and treatment of individualsadherence to pharmaceutical protocolsthe diagnosticprophylactic and therapeutic properties of pharmaceuticals; medical care consulting services in the fields of patient treatment and treatment protocols
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
14/01/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/01/2026
E815
TEAS SECTION 8 & 15 RECEIVED
08/10/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
14/07/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/02/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/02/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/02/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
25/05/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
25/05/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/05/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/05/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
25/05/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
14/07/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/06/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/06/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
19/05/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
19/05/2020
IUAF
USE AMENDMENT FILED
04/05/2020
EISU
TEAS STATEMENT OF USE RECEIVED
04/05/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/11/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/09/2019
PUBO
PUBLISHED FOR OPPOSITION
17/09/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/08/2019
ALIE
ASSIGNED TO LIE
09/08/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/07/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/07/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
29/07/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/05/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
29/01/2019
GNFR
FINAL REFUSAL E-MAILED
29/01/2019
CNFR
FINAL REFUSAL WRITTEN
29/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/12/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/12/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/12/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
20/06/2018
GNRT
NON-FINAL ACTION E-MAILED
20/06/2018
CNRT
NON-FINAL ACTION WRITTEN
20/06/2018
DOCK
ASSIGNED TO EXAMINER
12/06/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/03/2018
NWAP
NEW APPLICATION ENTERED
05/03/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RIGEL ONE CARE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.